Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A new nanoagent effectively kills bacteria and speeds up wound healing.

Combining fire needle therapy with doxycycline improves severe acne more than doxycycline alone.

High-dose methotrexate can cause severe skin and nail issues.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Platinum-based chemotherapy drugs can cause many severe side effects, often requiring dose reductions and additional medications to manage.